SPECIAL REPORTS
Can AI Help Extend Human Life? The Current State of Medical AI
From clinical trials on AI electrocardiogram (ECG) mortality to 2026 breast cancer screening and aging marker studies, this article analyzes the proven effects and remaining limitations of medical AI. It outlines the operational conditions required for medical institutions to translate more accurate predictions into actual improvements in survival and healthy lifespan.
Can people live longer if they take drugs created by artificial intelligence? The study on the aging markers of ziltivekimab released in September 2026 brought this question back to the surface. However, calculated values representing biological age and actual survival duration are different.…
KBR Access
Read this KBR Analysis article now
Buy this article for ₩3,900 (30 days of access), or get KBR+ 10 — 10 paid articles for ₩9,900 (₩990 each). KBR Members (free sign-up) read one paid article free every month.
✓ No account needed · Checkout is in Korean
Best value
KBR+ 10 · ₩9,900
An insight pass that opens 10 KBR+ articles, one at a time, whenever you like
10 KBR+ articles including KBR Analysis — ₩990 each. Use them within 60 days.
Get KBR+ 10KBR NEWSLETTER
Sign up for free and get the KBR Newsletter!
Sign up and opt in to the newsletter to receive KBR's curated business and economic insights by email.
LATEST IN TOPIC
Latest in this topic
Related Content
Tesla's Flying Roadster: How Much of Its Aerial Stunts Have Become Reality?
KBR+Why a Increase of 288,000 in Employment Insurance Subscribers is Hard to Read as a Sign of Ease in Hiring
KBR+Venture Investment Rebounds to KRW 8.9 Trillion: Did Invested Companies Grow at the Same Pace?
KBR+August Current Account Surplus at $46.11 Billion, Temperature Gap Between Semiconductors and Other Industries
